Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism RAS inhibitors(RAS type GTPase family inhibitors), SOS1 inhibitors(Son of sevenless homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H10N2O6S2 |
InChIKeyDJFUFNNDOAUACG-UHFFFAOYSA-N |
CAS Registry909197-38-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 01 Dec 2014 |